Elekta earns 2019 Medical Device Engineering Breakthrough award for MR-linac
Elekta has announced that MedTech Breakthrough, an...
Modernized Canadian Strategy for Cancer Control released
The Canadian Partnership Against Cancer (the...
ASCO '19: Positive results of lurbinectedin Phase II trial (PharmaMar) for relapsed NSCLC
The results of PharmaMar's (MSE: PHM) Phase II study with...
